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Abstract
Introduction: Near-infrared spectroscopy (NIRS) noninvasively measures peripheral tissue oxygen saturation (StO2).
NIRS may be utilized along with a vascular occlusion test, in which limb blood flow is temporarily occluded and
released, to quantify a tissue bed’s rate of oxygen exchange during ischemia and recovery. The objective of this
study was to test the hypothesis that NIRS-derived StO2 measures (StO2 initial, StO2 occlusion and StO2 recovery)
identify patients who are in shock and at increased risk of organ dysfunction (Sequential Organ Failure Assessment
(SOFA) score ≥ 2 at 24 hours) and dying in the hospital.
Methods: This prospective, observational study comprised a convenience sample of three cohorts of adult patients
(age > 17 years) at three urban university emergency departments: (1) a septic shock cohort (systolic blood
pressure < 90 after fluid challenge; the “SHOCK” cohort, n = 58), (2) a sepsis without shock cohort (the “SEPSIS”
cohort, n = 60) and emergency department patients without infection (n = 50). We measured the StO2 initial, StO2
occlusion and StO2 recovery slopes for all patients. Outcomes were sepsis syndrome severity, organ dysfunction
(SOFA score at 24 hours) and in-hospital mortality.
Results: Among the 168 patients enrolled, mean initial StO2 was lower in the SHOCK cohort than in the SEPSIS
cohort (76% vs 81%), with an impaired occlusion slope (-10.2 and 5.2%/minute vs -13.1 and 4.4%/minute) and an
impaired recovery slope (2.4 and 1.6%/second vs 3.9 and 1.7%/second) (P < 0.001 for all). The recovery slope was
well-correlated with SOFA score at 24 hours (-0.35; P < 0.001), with a promising area under the curve (AUC) for
mortality of 0.81. The occlusion slope correlation with SOFA score at 24 hours was 0.21 (P < 0.02), with a fair
mortality AUC of 0.70. The initial StO2 was significantly but less strongly correlated with SOFA score at 24 hours
(-0.18; P < 0.04), with a poor mortality AUC of 0.56.
Conclusions: NIRS measurements for the StO2 initial, StO2 occlusion and StO2 recovery slope were abnormal in
patients with septic shock compared to sepsis patients. The recovery slope was most strongly associated with
organ dysfunction and mortality. Further validation is warranted.
Trial registration: NCT01062685
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Severe sepsis currently accounts for > 500,000 emer-
gency department (ED) visits [1] and over 750,000 cases
annually in the United States [2]. While the etiologies
and presentations of sepsis remain extremely heteroge-
neous, the disease pathophysiology comprises a dysregu-
lated host response, activation of the inflammatory and
coagulation cascades, tissue hypoxia, cellular dysfunc-
tion, organ dysfunction and, if unmitigated, death.
Though biological questions and controversy remain,
there is widespread support for the basic principle that
early identification and timely supportive care, coupled
with antibiotic therapy and source control, result in
improved outcomes. As a result, current international
consensus guidelines for the resuscitation of patients
with severe sepsis and septic shock recommend aggres-
sive, invasive, protocol-directed care titrating to centrally
monitored parameters [3]. Unfortunately, central moni-
toring is not uniformly available and is often cited as a
barrier to guideline compliance [4]. A noninvasive and
reproducible measure of tissue hypoxia would be a valu-
able asset in the resuscitation armamentarium.
One option for noninvasive assessment of tissue
hypoxia is near-infrared spectroscopy (NIRS), which first
entered the medical field in 1977 as a method for mea-
suring oxygen levels in muscle and other tissues in vivo
[5]. With NIRS, it is possible to assess the ratio of oxy-
genated to deoxygenated hemoglobin, resulting in an
indirect measure of tissue oxygenation. NIRS has shown
promise as a tool to assess tissue oxygenation in a num-
ber of settings, including trauma, congestive heart failure
and sepsis. Its true diagnostic value and specific inter-
ventional role for guiding therapy require further study,
however. Additionally, the use of NIRS in conjunction
with vasoocclusive testing (VOT) is a tool with the
capacity to assess endothelial cell function, microcircula-
tory capacity and autoregulatory reserve (Figure 1).
Further study of the VOT procedure is required to
establish its true utility as prognostic indicator and an
end point of resuscitation.
To evaluate the utility of the aforementioned NIRS
parameters, we conducted an ED-based study of patients
presenting across a spectrum of sepsis severities, along
with age and sex matched non-infected control patients.
There are three main NIRS measurements reported in
the literature: (1) continuous tissue oxygen saturation
(StO2) measurement (StO2 initial), (2) StO2 occlusion
slope (StO2 downslope) in response to VOT testing and
3) StO2 recovery slope (StO2 upslope) in response to
VOT. In this study, we assessed the association of each
of these parameters with severity of illness, organ dys-
function and death. More specifically, the objective of
this study was to test the hypothesis that NIRS-derived
StO2 measures (StO2 initial, StO2 occlusion and StO2
recovery) are able to identify patients who are in shock
and at increased risk of organ dysfunction (Sequential
Organ Failure Assessment (SOFA) [6] score ≥ 2a t2 4
hours) and dying in the hospital.
Figure 1 Tissue oxygen saturation vasoocclusive testing. The initial slope, occlusion slope and recovery slopes are shown. During the initial
phase, the tissue oxygen saturation (StO2) level is monitored over time (initial). At occlusion, the tourniquet is programmed to insufflate a cuff to
50 mmHg above the patient’s systolic blood pressure. The StO2 level is then monitored during the ischemic period to calculate the steady-state
ischemic downslope (ischemic slope). This is postulated to represent a combination of oxygen content in the microcirculation and the metabolic
demand of the tissues. Next the cuff is released so that blood flow may be reestablished. The tissue is then reperfused, with the rate
representing the capacity to autoregulate and reperfuse the tissue exposed to regional ischemia (recovery slope). A patient with intact
endothelial cell function, microcirculation and oxygenation capacity will reperfuse quickly, yielding a steep recovery slope, while patients in
whom these mechanisms are impaired will have a shallower recovery slope.
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Study design and overall approach
We conducted a prospective, multicenter, observational
study of a convenience sample of patients who presented
to the ED of one of three large, urban, tertiary care facil-
ities. Three specific cohorts of patients (septic shock (the
“SHOCK” cohort), sepsis without shock (the “SEPSIS”
cohort) and uninfected controls) were assembled, encom-
passing a spectrum of sepsis severity. We collected perti-
nent demographic and clinical covariates as well as initial
StO2% and NIRS-derived measurements in response to
VOT testing. Then we analyzed the association and pre-
dictive ability of the NIRS measurements with our out-
comes of interest. The study was approved by the ethics
committees of each of the hospitals.
Assembly of cohorts
Three distinct cohorts of patients were enrolled. The
SHOCK cohort had to meet the American College of
Chest Physicians/Society of Critical Care Medicine cri-
teria for septic shock, specifically (1) suspected infection,
(2) fulfillment of two or more of the criteria for systemic
inflammatory response syndrome (SIRS) (temperature >
100.4°F or < 96.8°F, heart rate > 90 beats/minute,
respiratory rate > 20 breaths/minute or partial pressure
of carbon dioxide < 32 mmHg, white blood cell count >
12,000/μL or < 4,000/μLo r>1 0 %b a n d s )a n d( 3 )h y p o -
tension despite adequate fluid resuscitation (systolic
blood pressure (SBP) < 90 mmHg after 20 mL/kg crys-
talloids) [7]. The SEPSIS cohort had to meet the inclu-
sion criteria of suspected infection, two or more SIRS
criteria (see above) and no refractory hypotension. The
third cohort comprised uninfected ED control patients
who met the criteria of no suspected infection, no SIRS
criteria met and no evidence of hypoperfusion. The con-
trol patients were age-matched (by decade) as well as
sex- and race-matched to the SHOCK cohort.
A common set of exclusion criteria were applied to all
patient cohorts, which included any of the following: age
< 18 years, pregnancy, established “Do Not Resuscitate”
orders prior to enrollment, acute traumatic or burn
injury (primary diagnosis), acute cerebrovascular event
(primary diagnosis), acute coronary syndrome (primary
diagnosis), acute pulmonary edema (primary diagnosis),
cardiac dysrhythmia (primary diagnosis), acute and active
gastrointestinal bleeding (primary diagnosis), acute drug
overdose (primary diagnosis), requirement for immediate
surgery and inability to obtain written informed consent.
Clinical management at each institution is in agreement
with the Surviving Sepsis Campaign guidelines.
Demographic and clinical covariates
We collected demographic variables (age, sex and race),
comorbidities (cerebrovascular disease, chemotherapy,
congestive heart failure, chronic obstructive pulmonary
disease, dementia, diabetes, HIV or AIDS, Hodgkin’s
disease, intravenous drug use, leukemia, liver disease,
myocardial infarction, non-Hodgkin’s lymphoma, per-
ipheral vascular disease, renal disease, splenectomy, ster-
oid use, ulcer disease, transplant, presence of any
malignancy and residence in a nursing home), vital signs
data (temperature, blood pressure, heart rate, respiratory
rate and oxygen saturation) and pertinent laboratory
data (serum lactate, complete blood count, chemistry
panels, markers of coagulation and liver function tests).
NIRS assessment
The InSpectra StO2 Tissue Oxygenation Monitor (model
650; Hutchinson Technology, Hutchinson, MN, USA)
with probes spaced at 15 mm was utilized to obtain
StO2 measurements. The measurements were taken at
the thenar eminence during the resuscitation phase. Fol-
lowing a minimum initial five-minute stabilization per-
iod, we assessed the initial StO2 measurement and then
performed a VOT procedure using an automated tour-
niquet (Delfi Tourniquet System; Delfi Medical Innova-
tions, Inc, Vancouver, BC, Canada), which was
insufflated to 50 mmHg over the patient’s SBP for a per-
iod of three minutes. After three minutes, the cuff was
quickly removed. The subsequent StO2 tracing was ana-
lyzed offline to record the following NIRS-derived
metrics (see Figure 1) (1) StO2 initial, the baseline StO2
recorded after a five-minute stabilization period; (2)
StO2 occlusion, the steady-state rate of occlusion
(StO2%/second), represented by the descending slope
during the ischemic period; and (3) StO2 recovery, the
steady-state recovery slope during the reoxygenation
phase after the tourniquet was released. The StO2 mea-
surements were imported into a Microsoft Excel soft-
ware file (Microsoft Corporation, Redmond, WA, USA),
and the slopes were derived by (1) drawing a best-fit
line for the steady-state slope for the respective metric
and (2) calculating the slope.
Outcomes
We examined the association of StO2 parameters in
relation to three patient-oriented outcomes: (1) presence
of shock, as defined above, assessed at the time of
enrollment; (2) in-hospital mortality, defined as vital
signs status at hospital discharge; and (3) organ dysfunc-
tion at 24 hours assessed on the basis of the SOFA
scores calculated at the time of enrollment and 24 hours
later [6]. Consistent with prior publications, we defined
organ dysfunction as a SOFA score ≥ 2, which was our
primary outcome of interest. The use of a threshold
SOFA score ≥ 2 for an ill patient has previously been
established [8-10]. All patients in the control group with
missing SOFA scores at 24 hours (discharge was the
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a SOFA score < 2. For patients enrolled with a history
of chronic renal insufficiency or end-stage renal disease,
the renal SOFA score was not included in the total
SOFA score.
Data analysis
Descriptive statistics (means, standard deviations, med-
ians or proportions with percentiles) were reported for
demographics, clinical characteristics, vital signs and
laboratory values stratified by the three cohorts. We
compared mean (or median) values for the StO2 para-
meters of interest (initial, ischemic slope and reperfusion
slope) of the three different groups using the Wilcoxon
two-sample test. We used a Bonferroni correction to
address multiple testing; thus, for this analysis, Cron-
bach’s a < 0.017 was considered significant. Next, we
compared the StO2 parameters of interest for the out-
comes of in-hospital mortality and SOFA scores ≥ 2a t
24 hours. To assess the diagnostic accuracy for the StO2
parameters as a predictor of outcomes, we constructed
receiver operating characteristic curves (ROCs) and cal-
culated the area under the curve (AUC) along with the
95% confidence intervals (95% CIs). We used multivari-
ate logistic regression models to obtain adjusted esti-
mates for age, serum lactate and SBP and to identify the
StO2 parameters and adjustor variables with the stron-
gest independent associations with outcomes by using a
stepwise backward elimination technique with forward
examination of parameters eliminated after final model
selection. Throughout the analysis we used serum lac-
tate level as a comparison predictor.
Sample size calculation
Our study was powered on the ability of our anticipated
best StO2 readout (StO2 recovery slope) to discriminate
t h eS E P S I Sc o h o r tf r o mt h eS H O C Kc o h o r t .B a s e do n
previous studies, assuming mean changes in slope of 2.3
± 1.3 for the SHOCK group and 3.2 ± 1.4 for the SEP-
SIS group, with a power of 90% and Cronbach’s a set at
0.05, we calculated that approximately 60 patients per
group were needed [11]. We also enrolled 50 uninfected
controls as comparators for comparisons between con-
trols and the sepsis groups.
Results
Patient characteristics
We enrolled 170 patients in the study. However, two
patients in the SHOCK group were withdrawn from the
study (one voluntary withdrawal and one with incom-
plete StO2 data), leaving a total of 168 patients in the
study group. Of these, 58 had septic shock upon enroll-
ment, 60 had sepsis without shock and 50 were unin-
fected control patients. The mortality rates were 38% for
t h eS H O C Kc o h o r t ,5 %f o rt h eS E P S I Sc o h o r ta n d0 %
for the control group. The overall mean age for the
population was 63 years, of whom 60% were males
(Table 1). The SHOCK patients were older than the
SEPSIS patients but similar in age to the control
patients, since we matched these groups for age and sex.
The distribution of comorbidities was similar in the
three groups, but, as expected, the clinical characteristics
(for example, blood pressure) and laboratory values (for
example, serum lactate) commonly associated with
increased severity of illness were worse in the SHOCK
group.
Differentiation of SHOCK, SEPSIS and control cohorts
The mean values for the three main StO2 parameters of
interest, StO2 initial, ischemic slope and reperfusion
slope, were calculated and compared for the different
levels of sepsis syndrome and for controls upon enroll-
ment (Table 2 and Figures 2 through 4). The mean
values for all three parameters in the SHOCK patients
were significantly different from those in the SEPSIS
patients. However, the comparison between the SHOCK
patients and controls (who were age- and sex-matched)
revealed that only the upslope mean was significantly
different in the SHOCK vs control cohorts. Conversely,
the initial and ischemic slope means, but not the recov-
ery slope mean, were significantly different between the
SEPSIS and control groups.
Mortality prediction
For the mortality outcomes, we assessed the StO2 para-
meters obtained in the ED, as well as serum lactate, SBP
and age. The recovery slopes for patients who died were
significantly lower (mean ± SD: 1.7 ± 1.5 vs StO2%:
3.7%/second; P < 0.0001), with impaired oxygen recov-
ery observed among the nonsurvivors (Table 3). Simi-
larly, the ischemic slope was less steep, showing
decreased oxygen consumption during the vasoocclusion
phase of the VOT (mean ± SD: -8.8 ± 5.1 vs StO2%:
-12.0 ± 4.7%/second; P < 0.002). Both of these metrics
are postulated to represent impaired microcirculation
and a reduced capacity to exchange and deliver oxygen.
Initial StO2% did not differ significantly between the
survivors and nonsurvivors, nor did the mortality rate
differ when StO2 was stratified as < 80% or ≥ 80% (15%
vs 15%; P = 1.0). The AUC as a predictor of mortality
was 0.81 (95% confidence interval: 0.71 to 0.91) for the
recovery slope, 0.70 (0.57 to 0.83) for the ischemic slope
and 0.56 (0.43 to 0.69) for the initial slope. Serum lac-
tate levels were also increased in the nonsurvivors com-
pared to the survivors (4.7 ± 2.7 vs 1.9 ± 1.4 mmol/L; P
< 0.001), with an AUC of 0.85 for serum lactate. The
ROCs are shown in Figure 5. The multivariable logistic
regression model used to determine independent
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SBP and StO2 parameters. Using both forward and
backward selection techniques, the lactate and recovery
slopes were retained in the model as the strongest pre-
dictors of in-hospital mortality, regardless of cohort.
These two variables yielded an AUC for model discrimi-
nation of 0.88.
Organ dysfunction at 24 hours
Next, we assessed the StO2 parameters for their ability
to predict organ dysfunction, defined a priori as SOFA
score ≥ 2 at 24 hours. The initial and occlusion StO2
metrics, as well as serum lactate, SBP and age, were sig-
nificantly abnormal in patients with SOFA scores ≥ 2a t
24 hours compared to those with SOFA scores < 2
(Tables 4 and 5). The StO2 occlusion slope did not
show a statistically significant difference between the
groups. The AUC for the groups were initial slope, 0.61
(0.52 to 0.70); ischemic slope, 0.57 (0.48 to 0.66); recov-
ery slope 0.68 (0.59 to 0.76); and lactate slope 0.69 (0.61
to 0.78). The ROCs are shown in Figure 6. We also
examined the correlation between the NIRS parameters
at initial presentation and the total SOFA score and
found a correlation between StO2 initial slope (Spear-
man’s r correlation coefficient = -0.18; P < 0.04), occlu-
sion slope (Spearman’s r correlation coefficient = 0.21;
P < 0.02) and recovery slope (Spearman’s r correlation
coefficient = -0.35; P < 0.001).
Sensitivity analysis
W ec h o s et ou s et h ee n t i r es t u d yp o p u l a t i o na n d
included the uninfected control population in our ana-
lyses to assess mortality outcomes, as well as organ dys-
function at 24 hours, to take advantage of our full data
set. However, one could argue against this approach and
make the case for including only patients who fulfilled
Table 1 Selected demographic and medical history variables
a
Patient demographic variables Group (N = 168)
SHOCK (n = 58) SEPSIS (n = 60) Control (n = 50)
Age, years 68 ± 16 (72) 55 ± 17 (52) 68 ± 16 (72)
Weight, lb 180 ± 58 (175) 194 ± 59 (184) 165 ± 41 (165)
Male sex, n (%) 38 (66%) 38 (63%) 24 (48%)
History of coronary artery disease, n (%) 17 (29%) 13 (22%) 12 (24%)
Myocardial Infarction, n (%) 8 (14%) 5 (8%) 6 (12%)
Hypertension, n (%) 34 (59%) 33 (55%) 28 (56%)
Chronic obstructive pulmonary disease, n (%) 12 (21%) 10 (17%) 6 (12%)
Diabetes (any), n (%) 19 (33%) 17 (28%) 14 (28%)
Peripheral vascular disease, n (%) 3 (5%) 1 (2%) 4 (8%)
Renal disease, n (%) 15 (26%) 8 (13%) 10 (20%)
Serum lactate, mmol/L 3.5 ± 2.5 (3.0), 0.6 to 12.5 1.7 ± 1.1 (1.6), 0.4 to 5.2 1.4 ± 0.7 (1.1), 0.6 to 3.2
Systolic blood pressure, mmHg 100 ± 26 (99) 123 ± 26 (123) 138 ± 28 (138)
Mean arterial pressure, mmHg 75 ± 19 (69), 32 to 127 89 ± 16 (88),
65 to 129
96 ± 16 (96), 62 to 136
Respiratory rate, breaths/minute 26 ± 12 (24), 7 to 95 22 ± 6 (20), 14 to 42 20 ± 12 (18), 13 to 98
SaO2, % 97 ± 2 (98) 97 ± 3 (97) 96 ± 6 (97)
Temperature, °F 99.8 ± 3.1 (100.2) 100.0 ± 2.0 (100.3) 97.4 ± 0.8 (97.4)
White blood cell count, ×10
3/μL 14.6 ± 9.9 (12.2) 13.5 ± 9.6 (12.7) 7.1 ± 2.3 (6.6)
aSHOCK: the septic shock cohort (systolic blood pressure < 90 mmHg after fluid challenge); SEPSIS: the sepsis without shock cohort; Control: emergency
department patients without infection; SaO2: oxygen saturation of arterial blood. Data are means ± SD (medians) unless otherwise indicated.
Table 2 Vasoocclusive testing parameters at initial presentation
a
StO2 parameters Groups (N = 168) P values
SHOCK
(n = 58)
SEPSIS
(n = 60)
Control
(n = 50)
SHOCK vs SEPSIS SHOCK vs control SEPSIS vs control
Initial, % 76 ± 9
(78)
82 ± 7
(82)
79 ± 7
(79)
< 0.001* 0.23 < 0.02
Occlusion, %/second -10.2 ± 5.2 (-9.6) -13.1 ± 4.4 (-13.1) -11.3 ± 4.5 (-10.8) < 0.002* 0.21 < 0.03
Recovery, %/second 2.4 ± 1.6 (2.0) 3.9 ± 1.7 (4.1) 3.8 ± 1.7 (3.8) < 0.001* < 0.001* 0.52
aSHOCK: the septic shock cohort (systolic blood pressure < 90 mmHg after fluid challenge); SEPSIS: the sepsis without shock cohort; Control: emergency
department patients without infection; StO2: tissue oxygen saturation; *Wilcoxon two-sample test; statistically significant using P = 0.017 with the Bonferroni
correction. Data are means ± SD (medians).
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sis. Thus, we performed a subsequent sensitivity analysis
in which we limited the analysis to the 118 patients
enrolled from the SEPSIS and SHOCK groups. The
results of this analysis were very similar to those of our
primary analyses (Additional file 1 online data
supplement).
Discussion
In this multicenter study of ED patients who presented
across the spectrum of sepsis illness severity, we have
demonstrated that there is a potential role for noninva-
sive NIRS technology in patient assessment and risk
stratification. Moreover, we found that the use of NIRS
in conjunction with VOT testing, specifically as assessed
on the basis of the recovery slope, may hold the most
promise for use in the ED. The accuracy of recovery
slopes measured in the ED was similar to serum lactate
measurements with regard to the prediction of mortality
as well as organ dysfunction at 24 hours. These findings
remained robust in multivariate models. Additionally, in
the evolving era of goal-directed resuscitation protocols,
further investigation is needed to determine whether
NIRS, in combination with VOT testing, has a role in
guiding therapeutic efforts and has promise as a nonin-
vasive assessment of tissue oxygenation.
Our findings that VOT testing helped to optimize
NIRS diagnostic utility are consistent with the rationale
that measuring the body’s capacity to reoxygenate tissue
in response to the physiological perturbation of induced
Figure 2 Differences in initial, ischemic and recovery slopes stratified by sepsis severity. The boxplots are for initial tissue oxygen
saturation (StO2). The top and bottom lines of the box are the 25th and 75th percentiles, respectively. The middle line is the median. The
whiskers extend to the last data point within 1.5 quartile ranges of the box. The gray dots are the individual observed data points.
Figure 3 Differences in initial, ischemic and recovery slopes stratified by sepsis severity. Ischemic slope. The top and bottom lines of the
box are the 25th and 75th percentiles. The middle line is the median. The whiskers extend to the last data point within 1.5 quartile ranges of
the box. The gray dots are the individual observed data points.
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physiological function and reserve capacity. VOT is a
procedure whereby, for a limited time period (for exam-
ple, three minutes), blood flow to the muscle is inter-
rupted by using a tourniquet, allowing tissue
desaturation to occur. The ischemic tissue then induces
vasodilation of surrounding arterioles, metarterioles and
precapillary sphincters to decrease local vascular resis-
tance and regain blood flow. Next, as the tourniquet is
released and blood flow is restored, there is a reactive
hyperemic response which represents the tissue’sa b i l i t y
to autoregulate blood flow and oxygenation [12]. The
speed at which tissues are reoxygenated is proposed to
represent the reserve capacity and functionality of the
endothelium, mitochondria and microcirculation. Thus,
in the simplest terms, flow will quickly be restored in a
patient with intact autoregulatory capacity, resulting in a
steep recovery slope. A patient with dysfunction in any
of these components will manifest impaired reoxygena-
tion and a shallower recovery slope.
In fact, researchers in prior studies have reported
similar results. For example, in a 90-patient ICU-based
study (plus 18 healthy volunteers), Creteur et al. [11]
showed a significant association between a reduced
reperfusion slope after VOT testing and both shock and
mortality. The recovery slope outperformed the other
NIRS-derived variables. Payen et al. [13] also found a
depressed reperfusion slope in septic shock patients, as
did Skarda et al. [14]. Other researchers who have used
VOT testing have found increased StO2 recovery times
in patients with hemorrhagic shock [15], septic shock
[14] and peripheral vascular disease [16], including
patients in whom initial (preocclusion) StO2 readings
were high, > 75%. Accordingly, we submit that a pri-
mary message of our present study is that VOT testing
in conjunction with NIRS might hold the most diagnos-
tic potential.
While our results offer enthusiasm for the use of
NIRS-derived StO2 parameters, especially the reperfu-
sion slope, to predict adverse outcomes and
Table 3 Serum lactate, systolic blood pressure and InSpectra parameters stratified by in-hospital survival in all
groups
a
Parameter Died (n = 25) Survived (n = 143) P value* AUC (95% CI)
Serum lactate, mmol/L 4.7 ± 2.7 (4.2) (n = 24) 1.9 ± 1.4 (1.5) (n = 128) < 0.001 0.85 (0.76 to 0.93)
Systolic blood pressure, mmHg 105 ± 30 (102) 122 ± 30 (123) 0.004 0.68 (0.56 to 0.80)
Mean age, years 69 ± 14 (72) 62 ± 18 (67) 0.100 0.60 (0.49 to 0.72)
StO2
Initial (%) 76 ± 11 (79) 79 ± 7 (80) 0.341 0.56 (0.43 to 0.69)
Occlusion (%/minute) -8.8 ± 5.1 (-8.2) -12.0 ± 4.7 (-11.9) 0.002 0.70 (0.57 to 0.83)
Recovery (%/second) 1.7 ± 1.5 (1.3) 3.7 ± 1.7 (3.8) < 0.001 0.81 (0.71 to 0.91)
aAUC: area under the curve; 95% CI: 95% confidence interval; StO2: tissue oxygen saturation; *Wilcoxon two-sample test or Fisher’s exact test, as appropriate.
Data are means ± SD (medians).
Figure 4 Differences in initial, ischemic and recovery slopes stratified by sepsis severity. Recovery slope. The top and bottom lines of the
box are the 25th and 75th percentiles. The middle line is the median. The whiskers extend to the last data point within 1.5 quartile ranges of
the box. The gray dots are the individual observed data points.
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are not as promising and warrant further investigation.
For example, the StO2 initial slope (StO2 without
VOT) and the occlusion slope were unable to discri-
minate patients in septic shock from age-, sex- and
race-matched controls. StO2 initially had a poor AUC
(0.56) for mortality. The reperfusion slope was not sig-
nificantly different between patients with sepsis and
controls; however, that result was not entirely unex-
pected, as the conditions of many of the patients
meeting the sepsis definition were of low acuity.
While the performance of StO2 parameters in predict-
ing organ dysfunction were similar to the commonly
used marker of serum lactate, the AUCs for these
parameters (0.58 to 0.67) showed only fair
discrimination.
There are a number of additional limitations of this
study, which was designed to be only an initial look at
NIRS testing in the ED. We used a convenience sample
of patients and recruited a similar number of patients in
the SHOCK and SEPSIS groups, as well as an age-, sex-
and race-matched control group, which by definition
was enrolled in a nonconsecutive manner, thus exposing
our study to selection bias. Since we enrolled a skewed
population, we did not attempt to identify clinically use-
ful cutoff values that could be validated in future stu-
dies. We did not assess the reproducibility of our NIRS
measurements, which may threaten the reliability and
reproducibility of our overall results. We also measured
the slopes manually, which may affect the reproducibil-
ity of results. Our patient population included a limited
number of deaths, leaving our estimates of this outcome
with large 95% CIs. Our outcome measures of sepsis
syndrome at the time of enrollment and SOFA scores ≥
2 have been well-reported, but one may challenge their
clinical relevance. In this study, we did not follow
changes in StO2 measurements over time. There are a
number of other StO2 measurements that may be
derived as part of the VOT procedure that we did not
assess.
Conclusions
We conclude that NIRS-derived measurements, includ-
ing those that are part of a VOT protocol, hold promise
for risk stratification and patient assessment in the ED.
Further studies are warranted to assess the reproducibil-
ity of our findings and to determine the value of NIRS-
Figure 5 Receiver operating characteristic curves for mortality.
The receiver operating characteristic (ROC) curves for the initial
StO2, ischemic slope, recovery slope and serum lactate
measurements as predictors of in-hospital mortality are shown.
Table 4 Serum lactate and systolic blood pressure- and near-infrared spectroscopy-derived parameters stratified by
Sequential Organ Failure Assessment score at 24 hours for all groups
a
Parameter SOFA score ≥ 2 at 24 hours
# AUC (95% CI)
Yes (n = 65) No (n = 100) P value*
Serum lactate, mmol/L 3.1 ± 2.2 (2.1) 1.7 ± 1.5 (1.5) < 0.001 0.69 (0.61 to 0.78)
Systolic blood pressure 107 ± 27 (104) 128 ± 30 (126) < 0.001 0.71 (0.63 to 0.79)
Mean age, years 67 ± 17 (71) 61 ± 18 (64) 0.020 0.61 (0.52 to 0.70)
StO2
Initial (%) 77 ± 9 (79) 80 ± 7 (81) < 0.02 0.61 (0.52 to 0.70)
Occlusion (%/minute) -10.7 ± 4.9 (-10.6) -12.1 ± 4.8 (-11.6) 0.14 0.57 (0.48 to 0.66)
Recovery (%/second) 2.7 ± 1.9 (2.0) 3.8 ± 1.7 (3.9) < 0.001 0.68 (0.59 to 0.76)
aSOFA: Sequential Organ Failure Assessment; AUC: area under the curve; 95% CI: 95% confidence interval; StO2: tissue oxygen saturation.
#For patients in the
control group in which the SOFA score at 24 hours was not measured, a SOFA score < 2 was assumed. For patients with a history of chronic renal insufficiency
or end-stage renal disease, the total SOFA score used did not include the renal portion of the score. *Wilcoxon two-sample test or Fisher’s exact test, as
appropriate. Data are means ± SD (medians).
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citation protocol.
Key messages
￿ NIRS-derived StO2 measurements hold promise for
a role in risk stratification in ED patients with sepsis.
￿ Critically ill patients with sepsis have a reduced
rate of oxygen recovery as measured using NIRS in
response to VOT.
￿ The StO2 oxygen recovery slope was the best-per-
forming NIRS parameter, having the highest associa-
tion with shock, organ dysfunction and death.
Additional material
Additional file 1: Online data supplement: A sensitivity analysis
limiting the analysis to the 118 patients from the SEPSIS and
SHOCK groups who were enrolled in the study.
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